Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa in China
Phase of Trial: Phase III
Latest Information Update: 05 Jan 2015
At a glance
- Drugs Rasagiline (Primary)
- Indications Parkinson's disease
- Focus Registrational; Therapeutic Use
- Sponsors Lundbeck A/S
- 01 Jan 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 11 Apr 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 23 Mar 2012 New trial record